menopause hormone therapy billing

Menopause hormone therapy billing has become increasingly complex for OB-GYN practices in 2026. Many providers lose revenue due to undercoded E/M visits, telehealth billing errors, documentation gaps, and payer-specific hormone therapy restrictions. Counseling-heavy menopause visits often qualify for higher reimbursement, but improper coding and missing documentation reduce collections. Preventive visits combined with menopause evaluations may also require Modifier 25 for accurate billing. Reenix Excellence helps women’s health practices optimize reimbursement through specialty-focused billing support, telehealth compliance, denial prevention, documentation improvement, and payer-specific revenue cycle management strategies designed specifically for modern menopause care.

Read Detailed Blog @ https://reenixexcellence.com/article/menopause-hormone-therapy-billing-ob-gyn-practices-2026/